EDGE Biotechnologies

EDGE Biotechnologies combines advanced microscopy with AI-driven analytics to help accelerate early-stage biological discovery. The company provides direct, quantitative insight into how biological products behave inside cells, helping researchers understand mechanisms and identify promising candidates earlier.

Its technologies include 3D tissue bioimaging, which creates detailed fluorescent visualizations of biological tissues and their structures, and 4D cell bioimaging, which records cellular activity in real time. These tools enable observation and measurement of delivery, cell-entry pathways, and cellular fate. EDGE also offers AI-driven annotation and classification to extract quantitative biological information from bioimages rapidly and reproducibly.

The company’s services support early understanding of cellular mechanisms, more informed candidate selection, and the development of evidence that can strengthen regulatory submissions and intellectual property protection. Its visualizations and quantitative analyses can also help communicate efficacy and biological mechanisms for marketing and education. Founded by Ole Hjorth Krarup and Nikos Hatzakis, EDGE Biotechnologies invites organizations to discuss projects that could benefit from its imaging and analytics capabilities.